CD79B and Epstein-Barr virus infection: Besides, Vermaat et al. demonstrated a vital result of prominent mutual exclusivity between EBV infection, rearrangements, and MYD88/CD79B mutations, which established a distinct DLBCL subcategory in MYD88/CD79B-mutated tumors (40).